 |
 |
PDF
Oral levosimendan in patients with severe chronic heart failure—The PERSIST study
Nieminen et al. Eur J Heart Fail.2008;
10:
1246-1254
|
|
|
|
|
| To view this item, select one of the options below: |
|
|
|
 |
ESC Member and Congress Delegate Sign In |
|
Sign in here for free online access if your subscription to the European Journal of Heart Failure is via the European Society of Cardiology, either as a member* or an ESC Congress delegate.
*Discover if you are an ESC Member here. |
|
|
|
|
Sign In |
|
|
|
|
|
|
Purchase Short-Term Access |
|
 |
Pay per View - If you would like to purchase short-term access you must have a personal account. Please sign in with your personal user name and password or register to obtain a user name and password for free. You may access this article for 1 day for US$46.00. |
|
|
|
|
Login via Athens or your institution |
|
|
|
|
Register or Subscribe |
|
|
Subscribe to the Journal - Subscribe to the print and/or online journal. |
|
|
|
Register - Register online for access to selected content and to use Pay per View. Registration is free. |
|
|
|
|
